MedTrace Logo

Erectile Dysfunction After Percutaneous Coronary Intervention Versus the Thrombolytic Therapy in Acute ST Elevation Myocardial Infarction

NCT03328156 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-11-07

No results posted yet for this study

Summary

Erectile dysfunction is a common sexual problem affecting up to one-third of men throughout their life. It is now well recognized that risk factors for erectile dysfunction (ED) include the same risk factors as coronary artery disease, including smoking, dyslipidemia, diabetes, hypertension, lack of physical activity and obesity. We will investigate the effect of reperfusion strategies (primary angioplasty \& therapeutic therapy) on the prevalence of erectile dysfunction after acute myocardial infarction. Erectile function will be evaluated using the international index of erectile function after 3 months of successful reperfusion treatment of acute myocardial infarction.

Conditions

  • STEMI

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Yehia Taha Keshk, MD · Assiut University

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2018-10-01
Completion
2018-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03328156 on ClinicalTrials.gov